Sharda Cropchem Limited has reported consolidated financial results for the period ended March 31, 2025.

Sharda Cropchem has posted net profit of Rs. 203.56 crores for the period ended March 31, 2025 as against net profit of Rs. 31.14 crores for the period ended December 31, 2024. The company posted net profit of Rs. 143.46 crores for the period ended March 31, 2024.

Sharda Cropchem has reported total income of Rs. 1,853.75 crores during the period ended March 31, 2025 as compared to Rs. 929.94 crores during the period ended December 31, 2024. The company reported total income of Rs. 1,310.04 crores during the period ended March 31, 2024.

For the Financial Year ended March 31, 2025, Sharda Cropchem has reported total income of Rs. 4,379.38 crores as compared to Rs. 3,222.78 crores during the Financial Year ended March 31, 2024.

The company has posted net profit of  Rs. 304.37 crores for the Financial Year ended March 31, 2025 as against net profit of Rs. 31.88 crores for the Financial Year ended March 31, 2024.

Dividend: The Board of Directors have recommended a Final Dividend of Rs. 6 per Equity Share of Face Value of Rs.10 each of the Company (60% of FV)

Key Business Highlights for Q4 FY25

* Agrochemical Segment contributes 92%; Non-Agrochemical Segment contributes 8%

* Overall Volumes have increased by 49.8% in Q4 FY25 on Y-o-Y basis; Agrochemical volumes grew by 48.4% & Non-Agrochemical volumes grew by 115.6%

* Europe, NAFTA and LATAM have been key contributors for the volume growth Key Business Highlights for FY25

* Agrochemical Segment contributes 87%; Non-Agrochemical Segment contributes 13%

* Overall Volumes have increased by 42.1% Y-o-Y in FY25; Agrochemical volumes grew by 43.9% & Non-Agrochemical volumes grew by 9%

* Capex in FY25 stands at Rs. 420 crores

* Product Registrations stand at 2,964 with 1,014 applications globally pending at various stages as on 31st March 2025

* The Company remains Debt free with cash, bank and liquid investments of Rs. 558 crores

Commenting on the Results, Ramprakash Bubna, Chairman and MD, said, “During Q4 FY25, the Company has witnessed a revival in demand with Revenues growing by 39% YoY to Rs. 1,829 crores despite facing ongoing global challenges and sustained pricing pressures.

This resurgence has translated into a strong operational and financial performance in Q4 FY25, reflecting resilience in our business model and the effectiveness of the initiatives taken.

For FY25, Revenues grew by 37% YoY to Rs. 4,320 crores. Gross profit margins expanded by 400 basis points to 29.8%, demonstrating our pricing resilience amid global headwinds. EBITDA more than doubled to Rs. 682 crores, with EBITDA margins at 15.8%, aligning with our guidance.

Agrochemical volumes saw a robust growth of 44% during the year. With raw material prices stabilising, we expect consistency in gross margins going ahead. Our strong pipeline of registrations reflects both our resilience and unwavering commitment to growth, laying a strong foundation for sustained future progress. We are confident on our ongoing plan to increase product registrations in FY26 with capex guidance of Rs. 400-450 crores. For FY26, we aim to grow our topline by more than 15% while maintaining healthy EBITDA marginsin the range of 15–18%.”